Indoco Remedies approved the incorporation of a wholly owned subsidiary, Warren Lifesciences Private Limited, during its Committee of Executive Directors meeting on September 18, 2026. The company received name approval from the Registrar of Companies, Mumbai, and plans to incorporate the entity in due course.

The new subsidiary will operate within the pharmaceutical sector. Indoco intends for the entity to manufacture, develop, and sell pharmaceutical products, including active pharmaceutical ingredients, finished formulations, and key starting materials.

Transaction Details

The listed entity will hold 100% shareholding in the proposed company through a cash consideration. The shares will be subscribed at a face value of ₹10 per share.

The incorporation remains subject to approvals from the Registrar of Companies, the Ministry of Corporate Affairs, and other applicable statutory or regulatory bodies. The Committee meeting commenced at 5:15 pm and concluded at 5:45 pm.

Indoco Remedies disclosed the voting results of its 79th Annual General Meeting (AGM), held on September 17, 2026, at 10:30 am through Video Conferencing and Other Audio Visual Means.

AGM voting process and scrutinizer report

The company submitted the voting results, covering both remote e-voting and e-voting conducted during the AGM, to the stock exchanges in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The consolidated scrutinizer's report was prepared by CS Ajit Sathe, proprietor of M/s. A. Y. Sathe & Co., Practicing Company Secretary, Mumbai, appointed by the Board of Directors for this purpose.

The scrutinizer's mandate covered the process of voting by electronic means as prescribed under Section 108 of the Companies Act, 2013, read with Rule 20 and Rule 21 of the Companies (Management and Administration) Rules, 2014. The report captures votes cast in favour of and against the resolutions placed before members at the 79th AGM.

Remote e-voting and AGM e-voting details

The following table summarises the key procedural details of the voting exercise:

The AGM notice dated July 28, 2026 was sent to shareholders along with the Annual Report for the financial year 2025-2026, in electronic form only to members whose email addresses were registered with the company, Registrar and Share Transfer Agent, or Depository Participant.

Regulatory compliance and disclosures

The voting results and scrutinizer's report have been uploaded on the company's website as well as on the website of MUFG Intime India Private Limited. The submission was made by Ramanathan Hariharan, Company Secretary and Head Legal, Indoco Remedies Limited, on September 18, 2026.